The tweet was deleted by the author.
But we saved everything 🙂.
CVRx will address the integration of Barostim technology into heart failure care at the upcoming American Association of Heart Failure Nurses (AAHFN) Annual Meeting.
The session will feature expert faculty sharing practical insights on patient identification and selection, as well as collaboration between physicians and advanced practice providers. Through real-world case discussions, attendees can expect actionable guidance to enhance clinical outcomes with Barostim therapies.
CVRx recently marked a milestone with the first Barostim implant at Huntsville Hospital, expanding device therapy options for heart failure patients, according to a company announcement. Access to Barostim therapy has also grown through a partnership with RWJBarnabas Health at Robert Wood Johnson University Hospital, as reported in previous coverage. These collaborations reflect ongoing efforts to broaden availability of Barostim technology in clinical settings.